---
document_datetime: 2023-09-21 20:14:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/firazyr-epar-all-authorised-presentations_en.pdf
document_name: firazyr-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8269679
conversion_datetime: 2025-12-20 17:16:28.397289
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical              | Route of                        | Packaging                  | Content (concentration)   | Package size                                                  |
|-----------------|-----------------|------------|-----------------------------|---------------------------------|----------------------------|---------------------------|---------------------------------------------------------------|
| EU/1/08/461/001 | Firazyr         | 30 mg      | Form Solution for injection | Administration Subcutaneous use | pre-filled syringe (glass) | 3 ml (10 mg/ml)           | 1 pre-filled syringe + 1 needle                               |
| EU/1/08/461/002 | Firazyr         | 30 mg      | Solution for injection      | Subcutaneous use                | pre-filled syringe (glass) | 3 ml (10 mg/ml)           | 3 (3 x 1) pre-filled syringes + 3 (3 x 1) needles (multipack) |